It produces more modest results than semaglutide or tirzepatide, typically around 8 percent body weight loss, but it was the first GLP-1 to receive FDA approval specifically for weight management and remains a viable option for patients who prefer a shorter-acting medication or who experience intolerable side effects on the more potent formulations
Although rare, some patients taking Rybelsus and other GLP-1s have experienced NAION, a type of eye stroke that can cause painless, sudden, and often irreversible vision loss
The advantages of Mounjaros' heart health properties involve decreasing blood pressure and improving cholesterol levels, as well as alleviating symptoms of heart failure in individuals with preserved ejection fraction (HF pEF)
Henry Meds bundles everything into one monthly price with no separate consultation fees or hidden charges
For instance, the SUSTAIN 6 trial documented substantial reductions, underscoring the potential for cardiovascular benefits independent of glycemic control [63]